podcast
details
.com
Print
Share
Look for any podcast host, guest or anyone
Search
Showing episodes and shows of
Jose Lopez-Ribot
Shows
Tiene que haber algo más
122. José de La Luz López: Fundador de Delt.ai, COO de Albo. Hacer crecer emprendimientos, el mundo de las startups y el proceso de vender una compañía.
José es Cofundador de delt.ai que fue adquirida por Albo. Él tiene más de 10 años de experiencia en las áreas de finanzas y negocios trabajando en startups y grandes corporaciones. En esta conversación hablamos de cómo es vender una compañía, que lo llevó a ser monje budista tibetano mientras trabajaba en el banco, como se empieza a emprender y que se llevó él de pasar por Y Combinator, la mejor aceleradora de emprendimientos en San Francisco. *** Contenido: -Cómo se siente vender tu empre...
2024-04-02
51 min
microTalk
Into the Matrix: Fungal Biofilms with David Andes
Candida albicans is the most common fungal infection of humans. C. albicans can cause superficial infections like thrush or vaginitis when it overgrows within healthy individuals, but it causes much more serious disease when it infects immunocompromised individuals. C. albicans can form a matrix-encased biofilm on indwelling medical devices that serves as a source to seed systemic infections in patients. Dr. David Andes is a professor at the University of Wisconsin and also the chief of Division of Infectious Disease who studies fungal infections. Dr. Andes talks about the problem of fungal biofilms and antifungal...
2019-04-25
47 min
microTalk
Mycology Loquacity: Carol Kumamoto Gets Candid about Candida
Carol Kumamoto is a professor of microbiology at Tufts University. She studies Candida albicans, the most common fungal pathogen of humans. C. albicans is a normal commensal of the human body, and it typically does not cause any harm to people, but rather lives happily among the other microbes e.g. within the intestine. However when the host becomes immunocompromised, C. albicans will invade tissues and cause a life-threatening infection. Dr. Kumamoto talks about how C. albicans’ interactions with the other microbes within the body influences its virulence, the difficulty of developing antifungals that don’t harm...
2018-05-30
44 min
microTalk
It’s a Fungal Jungle Out There! A Discussion with Mary Ann Jabra-Rizk
Dr. Mary Ann Jabra-Rizk is an Associate Professor at the University of Maryland, where she studies the fungus Candida albicans and its interactions with the bacterium Staphylococcus aureus. C. albicans is a normal commensal fungus and S. aureus is also a common human commensal, but both are also opportunistic pathogens of humans. Fungi and bacteria are separated by several billion years of evolution, and yet Dr. Jabra-Rizk is studying how these organisms communicate with each other and team up to enhance their virulence. Dr. Jabra-Rizk talks about fungal-bacterial coinfections, the difficulty of effectively treating polymicrobial infections, and...
2018-03-27
54 min
microTalk
There’s Another Fungus Among Us! With Dr. Andrew Alspaugh
Dr. Andrew Alspaugh is a physician and Professor of Medicine at Duke University School of Medicine. Dr. Alspaugh is a mycologist, which means he studies fungi. Fungi typically cause serious and sometimes fatal disease in immunocompromised people. It is difficult to treat and prevent fungal diseases in these patients, due to their poorly functioning immune systems. Dr. Alspaugh is doing research on Cryptococcus neoformans, a common fungal infection of HIV-infected individuals. Dr. Alspaugh discusses fungal infections and the development of treatments and cures, his involvement in training mycologists at Woods Hole in Massachusetts, and how physician-patient interaction influences the...
2018-02-27
38 min
microTalk
There’s a Fungus Among Us!
Dr. Damian Krysan is a physician and an Associate Professor at the University of Rochester Medical Center. Dr. Krysan studies fungi, which in addition to their known roles in e.g. food spoilage and alcohol fermentation, can cause significant disease in humans. Fungi typically cause serious and potentially fatal disease in immunocompromised people, which presents a challenge to the medical community to come up with ways to treat and prevent fungal infections in this population. Dr. Krysan is doing research to identify new anti-fungal medications. Dr. Krysan discusses fungi and fungal infections, the difficulty of identifying new anti-fungal drugs...
2017-04-28
40 min